Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
287
-
Total 13F shares, excl. options
-
94,938,677
-
Shares change
-
-12,736,758
-
Total reported value, excl. options
-
$1,598,252,322
-
Value change
-
-$223,745,245
-
Put/Call ratio
-
53.32%
-
Number of buys
-
117
-
Number of sells
-
-137
-
Price
-
$16.83
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2021
354 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2021.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94,938,677 shares
.
Largest 10 shareholders include ARK Investment Management LLC (15,492,997 shares), GLENVIEW CAPITAL MANAGEMENT, LLC (9,115,521 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,386,303 shares), MACQUARIE GROUP LTD (4,740,712 shares), NORTHERN TRUST CORP (4,233,682 shares), Parametric Portfolio Associates LLC (3,772,537 shares), Mondrian Investment Partners LTD (3,703,404 shares), VANGUARD GROUP INC (2,496,142 shares), RENAISSANCE TECHNOLOGIES LLC (2,297,000 shares), and WELLS FARGO & COMPANY/MN (2,268,657 shares).
This table shows the top 287 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.